Home
Managed Care
Fatty Liver Solutions
Solutions for People at High Risk of Liver Cancer
Liver Health Assessment
Fast™ Calculator
aMAP Calculator
Subsidiaries and Products
FibroScan
Learn about FibroScan®
Find FibroScan ®
Compound Biejia Ruangan Tablets
Theraclion
Median
Investor Relations
News Center
Company News
Media Report
Industry News
Academic News
Popular Science Video
Career Development
About Furui
Company Introduction
ESG
Contact Us
Hot search
FibroScan®
Fatty Liver Solutions
Solutions for People at High Risk of Liver Cancer
English
Chinese
French
Home
Managed Care
Fatty Liver Solutions
Solutions for People at High Risk of Liver Cancer
Liver Health Assessment
Fast™ Calculator
aMAP Calculator
Subsidiaries and Products
FibroScan
Learn about FibroScan®
Find FibroScan ®
Compound Biejia Ruangan Tablets
Theraclion
Median
Investor Relations
News Center
Company News
Media Report
Industry News
Academic News
Popular Science Video
Career Development
About Furui
Company Introduction
ESG
Contact Us
News Center
Establish a global consensus on liver fibrosis and create a professional managed care group
Company News
Media Report
Industry News
Academic News
Popular Science Video
All years
2025
2024
2023
2022
2021
2020
2019
FXR激动剂对疑似纤维化NASH患者的肝脏和肾脏改善
2023-03-21
APASL2023 | 亚肝会热点话题之脂肪肝筛查与管理
2023-02-18
APASL2023 | SmartExam by FibroScan®在NAFLD中的应用优势
2023-02-18
逆转炎症：HCV治疗对生理年龄的长期影响
2023-01-07
2010-2019年全球肝癌流行病学变化：NASH为肝癌最快增长病因
2023-01-01
健康中国！肝纤维化中西医结合治疗新理念
2022-12-24
原发性肝癌三级预防共识（2022年版）指出复方鳖甲软肝片有助于降低肝癌复发风险
2022-12-22
Nature综述：近26%的瘦人也有脂肪肝，改善代谢失调是关键！
2022-12-17
Nature 综述：中国脂肪肝相关肝癌发病率将升高86%，急需预防！
2022-12-10
JOH丨南方医科大学陈金军教授团队：脾脏硬度测量可减少75%慢乙肝肝硬化的胃镜筛查
2022-11-10
AASLD中国之声丨侯金林/樊蓉教授团队：aMAP评分显著提高肝硬化无创性诊断的准确率
2022-11-08
首页
上一页
1
2
下一页
